Views: 4
Language: English
FDA APPROVES VISUDYNE THERAPY FOR AMD For Immediate Release
FDA APPROVES VISUDYNE THERAPY FOR AMD
A Major Advance in Ophthalmology
For Immediate Release April 12, 2000 ATLANTA, GEORGIA and VANCOUVER, CAN ... more>>
Tags: age-related macular degeneration,
choroidal neovascularization,
wet amd,
the eye,
clinical trials,
photodynamic therapy,
visual acuity,
macular degeneration,
dry amd,
amd patients,
vision loss,
intravitreal injection,
risk factors,
qlt inc,
visudyne therapy
Views: 0
Language:
Prospectus - QLT INC/BC - 3/31/2004 - QLT INC/BC - 3-31-2004
Filed Pursuant to Rule 424(b)(3) Registration No. 333-110306 PROSPECTUS $172,500,000 (AGGREGATE PRINCIPAL AMOUNT) QLT INC. 3.0% CONVERTIBLE SENIOR ... more>>
Tags: QLT INC BC,
QLT INC BC Prospectus,
QLTI Prospectus,
Prospectus - QLT INC BC - 3 31 2004,
Prospectus,
prospectus supplement,
net assets,
Mutual Fund,
Mutual Fund Prospectus,
the Notes,
fees and expenses,
Class A shares
Views: 0
Language: English
Prospectus - QLT INC/BC - 2/4/2004 - QLT INC/BC - 2-4-2004
PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-110306 $172,500,000 (AGGREGATE PRINCIPAL AMOUNT) QLT INC. 3.0% CONVERTIBLE SENIOR ... more>>
Tags: QLT INC BC,
QLT INC BC Prospectus,
QLTI Prospectus,
Prospectus - QLT INC BC - 2 4 2004,
Prospectus,
prospectus supplement,
net assets,
Mutual Fund,
Mutual Fund Prospectus,
the Notes,
fees and expenses,
Class A shares
Views: 0
Language: English
Prospectus - QLT INC/BC - 1/23/2004 - QLT INC/BC - 1-23-2004
PROSPECTUS Filed pursuant to Rule 424(b)(3) Registration No. 333-110306 $172,500,000 (AGGREGATE PRINCIPAL AMOUNT) QLT INC. 3.0% CONVERTIBLE SENIOR ... more>>
Tags: QLT INC BC,
QLT INC BC Prospectus,
QLTI Prospectus,
Prospectus - QLT INC BC - 1 23 2004,
Prospectus,
prospectus supplement,
net assets,
Mutual Fund,
Mutual Fund Prospectus,
the Notes,
fees and expenses,
Class A shares
Views: 0
Language: English
Prospectus - QLT INC/BC - 6/14/2004 - QLT INC/BC - 6-14-2004
Filed by: QLT Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act ... more>>
Tags: QLT INC BC,
QLT INC BC Prospectus,
QLTI Prospectus,
Prospectus - QLT INC BC - 6 14 2004,
Prospectus,
prospectus supplement,
net assets,
Mutual Fund,
Mutual Fund Prospectus,
the Notes,
fees and expenses,
Class A shares
Views: 0
Language: English
QLT Inc. 2006 Annual Report
QLT Inc. is a world leader in photodynamic therapy, a field of medicine utilizing light-activated drugs in the treatment of disease. QLT´s ... more>>
Views: 113
Language: